CYSTADROPS (Recordati Rare Diseases Australia Pty Ltd)
Product name
CYSTADROPS
Date registered
Evaluation commenced
Decision date
Approval time
218 (255 working days)
Active ingredients
mercaptamine (cysteamine)
Registration type
EOI
Indication
CYSTADROPS (eye drop solution) is indicated for the treatment of corneal cystine deposits in adults and children with cystinosis.
Registration process
Orphan drug
Sponsors receive a fee waiver to help bring medicines for a small population to market.